Bristol-Myers Squibb Announces Post-Closing Leadership Team

56

NEW YORK–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced the future leadership team of the combined company effective upon completion of the company’s pending merger with Celgene Corporation (NASDAQ:CELG). The company is evolving key aspects of its R&D and Commercialization structure to drive the continued growth of a highly successful marketed portfolio, maximize the six near-term launch opportunities and deliver the value of the combined pipeline, all guided by….

 

http://www.businesswire.com/news/home/20190605005469/en/Bristol-Myers-Squibb-Announces-Post-Closing-Leadership-Team